Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 103

1.

Differences in kinematics of the lumbar spine and lower extremities between people with and without low back pain during the down phase of a pick up task, an observational study.

Gombatto SP, D'Arpa N, Landerholm S, Mateo C, O'Connor R, Tokunaga J, Tuttle LJ.

Musculoskelet Sci Pract. 2017 Jan 5;28:25-31. doi: 10.1016/j.msksp.2016.12.017. [Epub ahead of print]

PMID:
28171775
2.

Development of the Virtual Physical Assessment Learning Material That Allows the Learners to Check Drug Efficacy and Early Detection of Adverse Effects through Virtual Experience.

Tokunaga J, Takamura N, Kourogi Y, Imada M, Kozasa A, Komori K, Ono C, Nishimura A, Ogata K, Setoguchi N, Matsuoka T, Kai M, Sato K, Arimori K.

Yakugaku Zasshi. 2016;136(10):1439-1444.

3.

Physical Assessment Education Using Various Simulators.

Tokunaga J, Takamura N, Ogata K, Setoguchi N, Sato K.

Yakugaku Zasshi. 2016;136(7):981-5. doi: 10.1248/yakushi.15-00286-3.

4.

An Endplate-Based Joint Coordinate System for Measuring Kinematics in Normal and Abnormally-Shaped Lumbar Vertebrae.

Berry DB, Rodríguez-Soto AE, Tokunaga JR, Gombatto SP, Ward SR.

J Appl Biomech. 2015 Dec;31(6):499-503. doi: 10.1123/jab.2015-0008.

5.

[Necessity of research of pharmaceutical departments in the creation of new pharmaceutical skills through technical education of physical assessment].

Takamura N, Tokunaga J, Ogata K, Setoguchi N.

Yakugaku Zasshi. 2015;135(2):185-8. doi: 10.1248/yakushi.14-00201-5. Review. Japanese.

6.

An advanced objective structured clinical examination using patient simulators to evaluate pharmacy students' skills in physical assessment.

Tokunaga J, Takamura N, Ogata K, Setoguchi N, Utsumi M, Kourogi Y, Osaki T, Ozaki M, Sato K, Arimori K.

Am J Pharm Educ. 2014 Dec 15;78(10):184. doi: 10.5688/ajpe7810184.

7.

A novel injection strategy of flurbiprofen axetil by inhibiting protein binding with 6-methoxy-2-naphthylacetic acid.

Ogata K, Takamura N, Tokunaga J, Ikeda T, Setoguchi N, Tanda K, Yamasaki T, Nishio T, Kawai K.

Eur J Drug Metab Pharmacokinet. 2016 Apr;41(2):179-86. doi: 10.1007/s13318-014-0248-z.

PMID:
25537338
8.

The circulating level of leptin and blood pressure in patients with multiple system atrophy.

Ozawa T, Tokunaga J, Arakawa M, Ishikawa A, Takeuchi R, Yokoseki A, Sone H, Nishizawa M.

J Neurol Sci. 2014 Dec 15;347(1-2):349-51. doi: 10.1016/j.jns.2014.09.045.

PMID:
25304054
9.

Influences of artificial heart-lung machine operation on the binding sites of albumin: possibility of an effective administration plan.

Totoribe K, Takamura N, Ogata K, Tokunaga J, Kawai K, Nakamura K, Ieiri I, Higuchi S.

Int J Artif Organs. 2014 Feb;37(2):99-108. doi: 10.5301/ijao.5000299.

10.

Albumin-binding of diclofenac and the effect of a site II inhibitor in the aqueous humor of cataract patients with the instillation of diclofenac.

Osaki T, Ozaki M, Takamura N, Ogata K, Tokunaga J, Setoguchi N, Arimori K.

Biopharm Drug Dispos. 2014 May;35(4):218-27. doi: 10.1002/bdd.1887.

PMID:
24395676
11.

Abnormal ghrelin secretion contributes to gastrointestinal symptoms in multiple system atrophy patients.

Ozawa T, Tokunaga J, Arakawa M, Ishikawa A, Takeuchi R, Mezaki N, Miura T, Sakai N, Hokari M, Takeshima A, Utsumi K, Kondo T, Yokoseki A, Nishizawa M.

J Neurol. 2013 Aug;260(8):2073-7. doi: 10.1007/s00415-013-6944-9.

12.
13.

A diclofenac suppository-nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritis.

Setoguchi N, Takamura N, Fujita K, Ogata K, Tokunaga J, Nishio T, Chosa E, Arimori K, Kawai K, Yamamoto R.

Biopharm Drug Dispos. 2013 Mar;34(2):125-36. doi: 10.1002/bdd.1829.

PMID:
23225308
14.

Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features.

Tsutsui K, Kanbayashi T, Tanaka K, Boku S, Ito W, Tokunaga J, Mori A, Hishikawa Y, Shimizu T, Nishino S.

BMC Psychiatry. 2012 May 8;12:37. doi: 10.1186/1471-244X-12-37.

15.

Preparation of simulation programs regarding excess-dose drug administration and acute-phase condition changes and its evaluation by students.

Tokunaga J, Takamura N, Ogata K, Setoguchi N, Matsuoka T, Sato K.

Yakugaku Zasshi. 2011 Apr;131(4):655-9.

16.

Prospective validation of quantitative fluorescent polymerase chain reaction for rapid detection of common aneuploidies.

Allingham-Hawkins DJ, Chitayat D, Cirigliano V, Summers A, Tokunaga J, Winsor E, Chun K.

Genet Med. 2011 Feb;13(2):140-7. doi: 10.1097/GIM.0b013e3182036763.

PMID:
21233717
17.

Vital sign monitoring using human patient simulators at pharmacy schools in Japan.

Tokunaga J, Takamura N, Ogata K, Yoshida H, Setoguchi N, Matsuoka T, Hirokane T, Yamaoka A, Sato K.

Am J Pharm Educ. 2010 Sep 10;74(7):132.

18.

[Survey of student pharmacists' attitudes toward new procedures expected for future pharmacists].

Tokunaga J, Takamura N, Ogata K, Yoshida H, Setoguchi N, Sato K.

Yakugaku Zasshi. 2010 Jun;130(6):911-6.

19.

[Life-support training to improve the clinical competence of pharmacy students].

Takamura N, Tokunaga J, Ogata K, Yoshida H, Setoguchi N.

Yakugaku Zasshi. 2010 Apr;130(4):583-8. Review. Japanese.

20.

Anti-human very late antigen-alpha4 (CD49d) monoclonal antibody (BU49) cross-reacts with the canine B-cell leukemia cell line GL-1, resulting in the induction of homotypic cell aggregation.

Ikewaki N, Nakaichi M, Mizuno T, Takamura N, Tokunaga J, Ogata K, Inoko H, Otsu R.

Cell Immunol. 2010;263(1):55-64. doi: 10.1016/j.cellimm.2010.02.016.

PMID:
20304388
Items per page

Supplemental Content

Loading ...
Support Center